Sachem Capital Corp. 8.00% Note (SCCG) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-0.49 et chiffre d'affaires de $0.06B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-0.93 vs est $-0.49 (manqué -91.1%). 2025: réel $0.04 vs est $0.02 (dépassé +144.4%). Précision des analystes: 47%.
Estimations du BPA — SCCG
47%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.93
vs Est –$0.49
▼ 47.7% off
2025
Actual $0.04
vs Est $0.02
▲ 59.1% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
Estimations du CA — SCCG
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.058B
vs Est $0.061B
▼ 6.5% off
2025
Actual $0.048B
vs Est $0.047B
▲ 2.8% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Les autres consultent aussi
